Publication | Closed Access

Structure–activity relationship in potentially anti-tumor promoting benzalacetone derivatives, as assayed by the Epstein–Barr virus early antigen activation

Structure–activity RelationshipMedicineImmunologyAntiviral ResponseAntiviral Drug DevelopmentBenzalacetone DerivativesImmunotherapeuticsAnti-cancer AgentPharmacologyViral OncologyTumor BiologyDrug DiscoveryCancer-associated Virus